Skin Autofluorescence Is Associated With 5-Year Mortality and Cardiovascular Events in Patients With Peripheral Artery Disease

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Arteriosclerosis, Thrombosis and Vascular Biology

• Publication date

  2014-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/ATVBAHA.113.302731PMID 24526694
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Advanced glycation end product associated skin autofluorescence: a mirror of vascular function?

  2013cited by this paper
• Skin Autofluorescence as a Measure of Advanced Glycation End Products Deposition Is Elevated in Peripheral Artery Disease

  2013cited by this paper
• Oxidation-specific biomarkers and risk of peripheral artery disease.

  2013cited by this paper
• High mortality risks after major lower extremity amputation in Medicare patients with peripheral artery disease.

  2013cited by this paper
• Serum pentosidine, an advanced glycation end product, indicates poor outcomes after acute ischemic stroke.

  2012cited by this paper
• Diagnosis and Classification of Diabetes Mellitus

  2011cited by this paper
• Skin autofluorescence is increased in patients with carotid artery stenosis and peripheral artery disease

  2011cited by this paper
• Skin autofluorescence as a measure of advanced glycation endproduct deposition: a novel risk marker in chronic kidney disease

  2010cited by this paper
• Skin color independent assessment of aging using skin autofluorescence.

  2010cited by this paper
• Carotid artery intima media thickness associates with skin autofluoresence in non‐diabetic subjects without clinically manifest cardiovascular disease

  2010cited by this paper
• Skin autofluorescence is elevated in acute myocardial infarction and is associated with the one-year incidence of major adverse cardiac events

  2009cited by this paper
• Advanced glycation end products in patients with cerebral infarction.

  2009cited by this paper
• Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus

  2009cited by this paper
• Elevation of the glycoxidation product Nε-(carboxymethyl)lysine in patients presenting with acute myocardial infarction

  2009cited by this paper
• Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the Modification of Diet in Renal Disease study equation for estimating glomerular filtration rate (Annals of Internal Medicine (2006) 145, (247-254))

  2008cited by this paper
• The HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advanced glycation, oxidative stress and inflammation

  2008cited by this paper
• Advanced glycation end products: sparking the development of diabetic vascular injury.

  2006cited by this paper
• ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography

  2006influential reference
• Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate

  2006cited by this paper
• Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients.

  2005cited by this paper
• Simple non-invasive assessment of advanced glycation endproduct accumulation

  2004cited by this paper
• Diagnosis and classification of diabetes mellitus

  2002cited by this paper
• Angiotensin II receptor antagonists and angiotensin-converting enzyme inhibitors lower in vitro the formation of advanced glycation end products: biochemical mechanisms.

  2002cited by this paper
• Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure.

  1997cited by this paper
• The role of glycation cross-links in diabetic vascular stiffening

  1996cited by this paper
• Mortality over a period of 10 years in patients with peripheral arterial disease.

  1992cited by this paper

• The roles of advanced glycation end products in cardiovascular diseases: from mechanisms to therapeutic strategies

  2025cites this paper
• Interpretable machine learning prediction model for major adverse cardiovascular events in patients with peripheral artery disease.

  2025cites this paper
• Association Between Skin Autofluorescence and Coronary Heart Disease in Chinese General Population: A Cross‐Sectional Study

  2025cites this paper
• Association between skin autofluorescence and all-cause mortality, cardiovascular mortality and cardiovascular disease: a systematic review and meta-analysis.

  2025cites this paper
• Association between advanced glycation end‐products and fall risk in older adults: The Yakumo Study

  2024cites this paper
• Metabolic memory: mechanisms and diseases

  2024cites this paper
• Advanced Glycation Endproducts: A Marker of Long-term Exposure to Glycemia

  2024cites this paper
• Skin autofluorescence and cause-specific mortality in a population-based cohort

  2024cites this paper
• Subcutaneous advanced glycation end products, cardiovascular risk factors and vascular health during childhood development in a Swiss population

  2024cites this paper
• Prognostic Factors and Models to Predict Mortality Outcomes in Patients with Peripheral Arterial Disease: A Systematic Review.

  2024cites this paper
• Non-contact measurement of neck pulses achieved by imaging micro-motions in the neck skin.

  2023cites this paper
• Skin autofluorescence as a factor of adverse prognosis in patients with peripheral atherosclerosis

  2023influential citation
• Association Between Skin Autofluorescence and White Blood Cell Counts in Older Adults

  2023cites this paper
• Skin Autofluorescence and Clinical Outcomes in Patients with Coronary Artery Disease

  2023cites this paper
• Multiphoton imaging of the monosachharide induced formation of fluorescent advanced glycation end products in tissues

  2023cites this paper
• The skin autofluorescence of advanced glycation end-products relates to the development of foot ulcers in type 2 diabetes: A longitudinal observational study.

  2023cites this paper
• Skin autofluorescence as an indicator of advanced glycation end-product accumulation in the prognosis of age-related cardiovascular disease: literature review

  2023cites this paper
• Associations between birth parameters and skin autofluorescence advanced glycation end products and ankle–brachial index in young adulthood: the Malmö Offspring Study

  2023influential citation
• Blood and Tissue Advanced Glycation End Products as Determinants of Cardiometabolic Disorders Focusing on Human Studies

  2023cites this paper
• Advanced glycation end products for preoperative frailty screening in older cardiac surgery patients.

  2023cites this paper
• Multiphoton imaging of glucose, galactose, and fructose-induced formation of fluorescent advanced glycation end products in tissues

  2023cites this paper
• Advanced glycation end products via skin autofluorescence as a new biomarker for major adverse cardiovascular events: A meta-analysis of prospective studies.

  2022cites this paper
• Correlation Between Skin Autofluorescence and Muscle Activities of Lower Limb in Aging Without Disease and Disability

  2022cites this paper
• Exercise, Advanced Glycation End Products, and Their Effects on Cardiovascular Disorders: A Narrative Review

  2022cites this paper
• Adjuvant aromatase inhibitor therapy and early markers for cardiovascular disease in breast cancer survivors

  2022cites this paper
• Skin autofluorescence of Advanced Glycation End-products and mortality in older adults: The roles of chronic kidney disease and diabetes.

  2022cites this paper
• Increased skin autofluorescence of advanced glycation end products (AGEs) in subjects with cardiovascular risk factors

  2022cites this paper
• Advanced Glycation End Products and Their Effect on Vascular Complications in Type 2 Diabetes Mellitus

  2022cites this paper
• Major Adverse Cardiac Events after Elective Infrarenal Endovascular Aortic Aneurysm Repair.

  2022cites this paper
• Skin accumulation of advanced glycation end products and cardiovascular risk in Korean patients with type 2 diabetes mellitus

  2022cites this paper
• Matrine inhibits advanced glycation end products-induced macrophage M1 polarization by reducing DNMT3a/b-mediated DNA methylation of GPX1 promoter.

  2022cites this paper
• The AGE reader: a non-invasive method to assess long term tissue damage.

  2021cites this paper
• Skin autofluorescence is associated with higher risk of cardiovascular events in Chinese adults with type 2 diabetes: A prospective cohort study from the Hong Kong Diabetes Biobank.

  2021cites this paper
• Skin autofluorescence predicts new cardiovascular disease and mortality in people with type 2 diabetes

  2021cites this paper
• Biophotonics methods for functional monitoring of complications of diabetes mellitus

  2020cites this paper
• For diabetic type 1 patients, the skin autofluorescence predicts ulcers and amputations.

  2020cites this paper
• Cardiovascular disease in COPD

  2020cites this paper
• Advances in understanding of mechanisms related to increased cardiovascular risk in COPD

  2020cites this paper
• Skin autofluorescence, a marker of glucose memory in type 2 diabetes

  2020cites this paper
• A physically active lifestyle is related to a lower level of skin autofluorescence in a large population with chronic-disease (LifeLines cohort)

  2020cites this paper
• Oxidative, nitrosative and glycosative stress levels in Crimean-Congo hemorrhagic fever disease

  2020cites this paper
• Skin autofluorescence of advanced glycation end products and course of affective disorders in the lifelines cohort study, a prospective investigation.

  2020cites this paper
• The Nitric Oxide System in Peripheral Artery Disease: Connection with Oxidative Stress and Biopterins

  2020cites this paper
• Skin autofluorescence in the general population: associations and prediction

  2019cites this paper
• Photoacoustic computed tomography of human extremities

  2019cites this paper
• Advanced Glycation End Products and Risks for Chronic Diseases: Intervening Through Lifestyle Modification

  2019cites this paper
• Cardiometabolic risk and subclinical vascular damage assessment in idiopathic inflammatory myopathies: a challenge for the clinician.

  2019influential citation
• Skin autofluorescence is associated with rapid renal function decline in subjects at increased risk of coronary artery disease

  2019cites this paper
• Role of Advanced Glycation Endproduct (AGE)-Receptor for Advanced Glycation Endproduct (RAGE) Axis in Cardiovascular Disease and Its Therapeutic Intervention.

  2019cites this paper
• Role of Ligands of Receptor for Advanced Glycation End Products (RAGE) in Peripheral Artery Disease

  2018cites this paper
• Autofluorescence of Skin Advanced Glycation End Products as a Risk Factor for Open Angle Glaucoma: The ALIENOR Study.

  2018cites this paper
• Relationship between advanced glycation end-product accumulation in the skin and pulmonary function

  2018cites this paper
• Influence of Physical Exercise on Advanced Glycation End Products Levels in Patients Living With the Human Immunodeficiency Virus

  2018cites this paper
• Skin autofluorescence predicts incident type 2 diabetes, cardiovascular disease and mortality in the general population

  2018cites this paper
• The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review

  2018cites this paper
• Skin Autofluorescence–Indicated Advanced Glycation End Products as Predictors of Cardiovascular and All‐Cause Mortality in High‐Risk Subjects: A Systematic Review and Meta‐analysis

  2018cites this paper
• Oxidative stress and antioxidant treatment in patients with peripheral artery disease

  2018cites this paper
• Diabetes mellitus and rhegmatogenous retinal detachment Fokkens ,

  2017cites this paper
• Assessment of Ocular Accommodation in Humans

  2017cites this paper
• Relationship between advanced glycation end‐product accumulation and low skeletal muscle mass in Japanese men and women

  2017cites this paper
• Skin advanced glycation end products in HIV infection are increased and predictive of development of cardiovascular events

  2017cites this paper
• Prediction and monitoring of chronic kidney disease

  2017cites this paper
• Advanced glycation end products as a biomarker for incisional hernia

  2017cites this paper
• Skin autofluorescence, a non-invasive marker of advanced glycation end products: clinical relevance and limitations

  2017cites this paper
• GPR56/ADGRG1 Inhibits Mesenchymal Differentiation and Radioresistance in Glioblastoma.

  2017cites this paper
• Skin autofluorescence (a marker for advanced glycation end products) and erectile dysfunction in diabetes.

  2017cites this paper
• Skin accumulation of advanced glycation end products is increased in patients with an abdominal aortic aneurysm

  2017cites this paper
• Diverging effects of diabetes mellitus in patients with peripheral artery disease and abdominal aortic aneurysm and the role of advanced glycation end-products: ARTERY study — protocol for a multicentre cross-sectional study

  2017cites this paper
• Skin autofluorescence improves the Finnish Diabetes Risk Score in the detection of diabetes in a large population-based cohort: The LifeLines Cohort Study.

  2017cites this paper
• Advanced glycation end‐products (AGEs) and associations with cardio‐metabolic, lifestyle, and dietary factors in a general population: the NQplus study

  2017cites this paper
• A Potential Mechanism for Diabetic Wound Healing: Cutaneous Environmental Disorders

  2016cites this paper
• Traditional and emerging indicators of cardiovascular risk in chronic obstructive pulmonary disease

  2016cites this paper
• Effect of glycation inhibitors on aging and age-related diseases.

  2016cites this paper
• Advanced glycation end products in patients with peripheral artery disease

  2016cites this paper
• Cellular mechanisms and consequences of glycation in atherosclerosis and obesity.

  2016cites this paper
• Relationship between skin autofluorescence and skeletal muscle mass

  2016cites this paper
• Autofluorescence cutanée des produits de glycation avancée (AGE), mémoire métabolique et complications du diabète

  2016cites this paper
• Analysis of advanced glycation end products in the DHS Mind Study.

  2016cites this paper
• A Comparative Study on Skin and Plasma Advanced Glycation End Products and Their Associations with Arterial Stiffness

  2016cites this paper
• Association of Skin Autofluorescence Levels With Kidney Function Decline in Patients With Peripheral Artery Disease

  2016cites this paper
• Lifestyle and clinical determinants of skin autofluorescence in a population‐based cohort study

  2016cites this paper
• Skin advanced glycation end-products evaluation in infants according to the type of feeding and mother’s smoking habits

  2016cites this paper
• Diverging effects of diabetes mellitus in patients with peripheral artery disease and abdominal aortic aneurysm and the role of advanced glycation end products: ARTERY study. Protocol for a multicenter cross-sectional study

  2016cites this paper
• Advanced glycation end products: An emerging biomarker for adverse outcome in patients with peripheral artery disease.

  2016cites this paper
• Analyse épidémiologique du glaucome dans une population âgée : l'étude ALIENOR (Antioxydants, Lipides Essentiels, Nutrition et maladies Occulaires)

  2016cites this paper
• Genetic and biochemical analysis of type 2 diabetes and diabetic complications

  2015cites this paper
• Skin Autofluorescence as a Measure of Advanced Glycation End Products Deposition Predicts 5-Year Amputation in Patients With Peripheral Artery Disease

  2015influential citation
• Emerging Risk Biomarkers in Cardiovascular Diseases and Disorders

  2015cites this paper
• Evaluation of tissue accumulation levels of advanced glycation end products by skin autofluorescence: A novel marker of vascular complications in high-risk patients for cardiovascular disease.

  2015cites this paper
• sRAGE, inflammation, and risk of atrial fibrillation: results from the Atherosclerosis Risk in Communities (ARIC) Study.

  2015cites this paper
• Étude prospective de la valeur de l’autofluorescence cutanée comme marqueur prédictif de l’apparition ou d’aggravation des complications chez les patients diabétiques de type 1

  2015cites this paper
• Advanced glycation end products and schizophrenia: A systematic review.

  2015cites this paper
• Vitamin D status is associated with skin autofluorescence in patients with type 2 diabetes mellitus: a preliminary report

  2015cites this paper
• Tissue advanced glycation end products (AGEs), measured by skin autofluorescence, predict mortality in peritoneal dialysis

  2015cites this paper
• [Correlations between skin autofluorescence and conventional glycemic markers in patients with diabetes].

  2015cites this paper
• [The Relationship Between Level of End-Products of Tissue Glycation and Pulse Wave Velocity in Non-diabetic Patients With Cardiovascular Disease].

  2015cites this paper
• Apolipoprotein B attenuates albuminuria-associated cardiovascular disease in prevention of renal and vascular endstage disease (PREVEND) participants.

  2014cites this paper
• Skin autofluorescence, 5-year mortality, and cardiovascular events in peripheral arterial disease: all that glitters is surely not gold.

  2014cites this paper
• Diet and glycaemia: the markers and their meaning. A report of the Unilever Nutrition Workshop

  2014cites this paper
• Skin Autofluorescence - A Non-invasive Measurement for Assessing Cardiovascular Risk and Risk of Diabetes.

  2014cites this paper